JPH04186163A - Automatic analyzing device - Google Patents
Automatic analyzing deviceInfo
- Publication number
- JPH04186163A JPH04186163A JP31395790A JP31395790A JPH04186163A JP H04186163 A JPH04186163 A JP H04186163A JP 31395790 A JP31395790 A JP 31395790A JP 31395790 A JP31395790 A JP 31395790A JP H04186163 A JPH04186163 A JP H04186163A
- Authority
- JP
- Japan
- Prior art keywords
- data
- function
- sample
- judgment
- memory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Automatic Analysis And Handling Materials Therefor (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は異常となった検体の救済処理方法に関−’ −
−455
する。[Detailed Description of the Invention] [Field of Industrial Application] The present invention relates to a method for remedial treatment of abnormal specimens.
-455 Yes.
従来の装置は、反応過程データのみのメモリ格納機能は
あったが、そのデータを使って再泪算するという機能は
無かった。Conventional devices had a memory storage function for only reaction process data, but did not have a function to recalculate using that data.
上記従来技術は、測定した結果のみ(○に/NG)又は
特定の項目の反応過程のデータだけをメモリに格納する
と云う機能はあったが、異常検体の場合には条件を再設
定しなおして測定すると云う具合に、検体試料及び試薬
、時間のムダと云う点について配慮がされておらず問題
であった。The above conventional technology had a function of storing only the measured results (○/NG) or only the reaction process data of a specific item in the memory, but in the case of an abnormal sample, the conditions had to be reset. There was a problem in that no consideration was given to the waste of specimen samples, reagents, and time during measurements.
本発明は、反応過程のデータを基に条件を再設定しなお
して再計算をさせることを目的としており、さらに再計
算で異常から正常に変った検体については人間の判断に
より正常になったことを知らしめる印を付けることを目
的とする。The purpose of the present invention is to reset the conditions and recalculate based on the data of the reaction process, and furthermore, if a sample changes from abnormal to normal in the recalculation, it is determined by human judgment that it becomes normal. The purpose is to put a mark to let people know.
上記目的を達成するために、絶えず反応過程のデータを
メモリ(RAM、FD等)に格納する機能を設けたもの
である。In order to achieve the above object, a function is provided to constantly store reaction process data in a memory (RAM, FD, etc.).
また、異常検体を救済するためには、条件を再設定しな
おし、反応過程データを使い再計算する機能を設け、ま
た再計算の結果、異常から正常に変わった検体には印(
マーク)を付ける機能を設けたものである。In addition, in order to rescue abnormal samples, we have set up a function to reset the conditions and recalculate using reaction process data, and as a result of recalculation, samples that change from abnormal to normal are marked (
It has a function to add marks).
測定中の反応過程のデータは、メモリ(RAM。 Data on the reaction process being measured is stored in memory (RAM).
FD等)に格納され、測定終了後にCR1”等の表示媒
体に呼び出すことができる。特に、異常と判断された検
体の反応過程のデータを呼び出し、条件の再設定をしな
おすことにより再計算をし異常から正常になった検体に
は印を付は後で機械が判断したものか人間が判断したも
のかが判るようになる。そうすることにより、異常検体
の患者から採血をしなおすと云う時間及び血液のムダを
無くすことができる。FD, etc.), and can be called up on a display medium such as CR1" after the measurement is completed. In particular, data on the reaction process of a sample judged to be abnormal can be called up and recalculations can be performed by resetting the conditions. However, if a sample changes from abnormal to normal, it will be marked and later it will be possible to tell whether the judgment was made by the machine or by a human.By doing so, blood can be re-collected from the patient with the abnormal sample. Waste of time and blood can be eliminated.
[実施例]
以下、本発明の一実施例を第1図〜第6図を用いて説明
する。[Example] An example of the present invention will be described below with reference to FIGS. 1 to 6.
第1図は、本発明を実施しようとする臨床検査 ′用
自動分析装置の概略図である。サンプルテーブル1上に
セットされた試料の入った試料容器2へ、ノズル3をさ
さえているアーム4が下降し、試料を吸入したのちアー
ム4が」1昇、回転して、反応テーブル5にセットしで
ある反応容器6に試料を分注し、散乱光の変化を測定す
る。散乱光の変化の測定は、反応容器6の底にある光源
7より照射された光が、反応容器6内で凝集反応が開始
されると散乱し、側方検知器8によってとらえられる。FIG. 1 is a schematic diagram of an automatic analyzer for clinical testing in which the present invention is implemented. The arm 4 supporting the nozzle 3 descends into the sample container 2 containing the sample set on the sample table 1, and after inhaling the sample, the arm 4 rises 1", rotates, and sets it on the reaction table 5. A sample is dispensed into a reaction container 6, and the change in scattered light is measured. To measure changes in scattered light, light emitted from a light source 7 at the bottom of the reaction vessel 6 is scattered when an agglutination reaction is initiated within the reaction vessel 6, and is detected by a side detector 8.
測方検知器8を通過した信号は、例えば第2図に示すロ
ックインアンプlO1対数変換器11.A/D変換器1
2を経由してCPU13により記憶素子(RAM)1’
5へ格納される。信号は一定時間毎(例えば0.1秒毎
i:) CPUI 3ニヨリRAM15へ格納され、ま
た遂次演算も行なわれ結果をプリンタ16やCRT17
へ印字又は表示する。The signal that has passed through the measurement detector 8 is sent to the lock-in amplifier lO1 logarithmic converter 11 . A/D converter 1
Memory element (RAM) 1' by the CPU 13 via 2
5. The signal is stored in the RAM 15 at fixed intervals (for example, every 0.1 seconds), and calculations are performed sequentially, and the results are sent to the printer 16 or CRT 17.
Print or display on.
ここで、凝固の判定について第3図〜第5図を用いて説
明する。Here, determination of coagulation will be explained using FIGS. 3 to 5.
凝集反応の進行に伴なって増加する散乱光の時量変化は
第3図のような形をする。凝固時間の判定は、この波形
(第3図)の傾斜が最も大きくなる位置Q、1 を凝固
点とし、測定開始からこの凝固点までの時間を凝固時間
と云う。凝固時間の判定には諸々の諸条件を満たさなけ
ればならない。その第一に、−次微分波形(第4図)を
とり、−次微分値がある一定のしきい値(以後、スレッ
シュホールドレベルC1と云う)以上で、かつ二重積分
波形(第5図)に於いて、二重積分値(第3図の斜線部
分の面積に相当する)がある一定のしきい値(以後、ス
レッシュホールドレベルC2と云う)以上であること等
の条件を同時に満たすとき、Tを凝固時間とする。この
スレッシュホールドレベルCI、C2は反応過程で生ず
る浮遊微粒子や気泡等によるノイズ信号P2とを区別し
て判断する為に安全率を加味した値に設定されるのが通
常である。しかし、現実にはこのスレッシュホールドレ
ベルCI、C2の設定が非常に困難で、全ての患者検体
を満足できないのが現状である。The temporal change in the amount of scattered light that increases as the aggregation reaction progresses takes the form shown in FIG. In determining the coagulation time, the position Q,1 where the slope of this waveform (Fig. 3) is the largest is defined as the coagulation point, and the time from the start of measurement to this coagulation point is called the coagulation time. Various conditions must be met to determine the clotting time. First, a -th differential waveform (Fig. 4) is taken, and the -th differential value is above a certain threshold (hereinafter referred to as threshold level C1), and the double integral waveform (Fig. 5) is taken. ), when the conditions such as the double integral value (corresponding to the area of the shaded area in Figure 3) being above a certain threshold (hereinafter referred to as threshold level C2) are simultaneously satisfied. , T is the clotting time. These threshold levels CI and C2 are normally set to values that take into account a safety factor in order to distinguish them from the noise signal P2 due to floating particles, bubbles, etc. generated during the reaction process. However, in reality, it is very difficult to set these threshold levels CI and C2, and the current situation is that they cannot be satisfied for all patient samples.
このような条件のもと、演算の結果未凝固となった検体
の生データ(反応過程データ)及び測定結果をRAM1
5からフロッピーディスク19へ転送し、いつでも読み
出しができ、その生データの波形(第3図)を見ながら
再計算をさせ、−次微分波形(第6図)に於いて明かに
ピークがあるにもかかわらず、スレッシュホールドレベ
ルC1が高く設定されである為に未凝固と判定している
ものについては、人間の判断によってスレッシュホール
ドレベルC1の値を下げ、再計算をして凝固時間を得る
。人間の判断によって得られた結果には、目印(マーク
)を付けてフロッピーディスク19に再格納され、後で
結果のみ出ノJされたとき、装置が判断したものか人間
が判断したものかを識別することができる。Under these conditions, raw data (reaction process data) and measurement results of the sample that became uncoagulated as a result of calculation are stored in RAM1.
5 to the floppy disk 19, which can be read out at any time, and recalculated while looking at the waveform of the raw data (Fig. 3). It was found that there was a clear peak in the -order differential waveform (Fig. 6). However, if the threshold level C1 is set too high and is determined to be uncoagulated, the value of the threshold level C1 is lowered by human judgment and the coagulation time is obtained by recalculating. The results obtained by human judgment are re-stored on the floppy disk 19 with a mark attached, and when the results are output later, it is possible to identify whether the results were determined by the device or by a human. can be identified.
また、測定開始前にキーボード18がら未凝固検体の波
形を表示する/しないの設定をしておき、するを選択し
た場合には、測定終了時に未凝固検体の一次微分波形を
全て表示させ、ユーザーに判断をあおがせる。In addition, before starting the measurement, you can set whether to display the waveform of the uncoagulated sample using the keyboard 18, and if you select Yes, all the first-order differential waveforms of the uncoagulated sample will be displayed at the end of the measurement, allowing the user to to influence judgment.
本実施の例によれば、明らかに凝固しているにもかかわ
らず、スレッシュホールドレベルCI。According to the present example, the threshold level CI is maintained even though the solidification is clearly occurring.
C2の設定が誤った為に未凝固と判断され、再検査する
と云うムダを無くすことができる。特に、幼児とかあま
り血液の採れない患者から得た血漿(検体)をムダにす
ることは許されないので、このモードの必要性はきわめ
て大きい。It is possible to eliminate the waste of having to re-examine the product because it is determined that the product is not coagulated due to an incorrect C2 setting. In particular, it is unacceptable to waste plasma (specimen) obtained from infants and other patients whose blood collection is difficult, so this mode is extremely necessary.
[発明の効果]
本発明によれば、測定終了時に全ての未凝固検体の一次
微分波形かCRTに表示されたり、またフロッピーディ
スクから任、・五の未凝固検体の一次微分波形か呼び出
し表示することにより、そのデータの確認ができ機械の
判断誤りを防ぎ、その誤りによる再検を防ぐ効果がある
。[Effects of the Invention] According to the present invention, at the end of the measurement, the first-order differential waveforms of all uncoagulated samples are displayed on the CRT, or the first-order differential waveforms of any number of uncoagulated samples can be called up and displayed from the floppy disk. By doing so, the data can be confirmed, preventing errors in judgment by the machine, and having the effect of preventing re-examinations due to errors.
第1図は本発明の一実施例の機構概略図、第2図は信号
系ブロック図、第3図は凝固信号(オリジナル波形)図
、第4図はオリジナル波形を一次微分した一次微分波形
図、第5図は二重積分波形図、第6図はスレッシュホー
ルドレベルCIを高く設定したときの一次微分波形図で
未凝固と判断された図である。
1 ・サンプルテーブル、2・・・試料容器、3・・・
ノズル、4・・・サンプルアーム、5・・反応テーブル
、6・・反応容器、7・・・光源、8・・・側方検知器
、9・・・光源ドライバ、10・・・ロックインアンプ
、11・・対数変換器、12・・・A/D変換器、13
・・・CPU、14・・・ROM、15・・・RAM、
16・・・プリンタ、17・・・CRT、18・・・キ
ーボード、19・・・フロラ謔 さ 、Fig. 1 is a schematic diagram of the mechanism of an embodiment of the present invention, Fig. 2 is a signal system block diagram, Fig. 3 is a coagulation signal (original waveform) diagram, and Fig. 4 is a first-order differential waveform diagram of the original waveform. , FIG. 5 is a double integral waveform diagram, and FIG. 6 is a first-order differential waveform diagram when the threshold level CI is set high, and is determined to be non-coagulated. 1 ・Sample table, 2...sample container, 3...
Nozzle, 4...Sample arm, 5...Reaction table, 6...Reaction container, 7...Light source, 8...Side detector, 9...Light source driver, 10...Lock-in amplifier , 11... Logarithmic converter, 12... A/D converter, 13
...CPU, 14...ROM, 15...RAM,
16...Printer, 17...CRT, 18...Keyboard, 19...Flora song,
Claims (1)
スク、その他)に格納する機能を有する装置に於いて、
測定結果のみならず、異常検体の反応過程データをもメ
モリに格納する機能を設け、そのデータをいつでもCR
T等の表示媒体に表示して見られるようにし、装置では
判断しにくいものを人間(医師及び検査技師)の判断に
委ねる機能を設けたことを特徴とする自動分析装置。 2、請求項第1項において、人間の判断に委ねたデータ
には印が付られ、後で見て機械が判断したものか人間が
判断したものかが識別できることを特徴とする自動分析
装置。[Claims] 1. In an apparatus having a function of constantly storing measurement results in a memory (RAM, floppy disk, etc.),
A function is provided to store not only measurement results but also reaction process data of abnormal samples in memory, and that data can be accessed at any time by CR.
An automatic analysis device characterized by being provided with a function to display on a display medium such as a T-shirt and leave things that are difficult to judge by the device to the judgment of humans (physicians and laboratory technicians). 2. The automatic analysis device according to claim 1, characterized in that the data left to human judgment is marked with a mark, so that it can be later identified whether the data was judged by a machine or by a human.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31395790A JPH04186163A (en) | 1990-11-21 | 1990-11-21 | Automatic analyzing device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31395790A JPH04186163A (en) | 1990-11-21 | 1990-11-21 | Automatic analyzing device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH04186163A true JPH04186163A (en) | 1992-07-02 |
Family
ID=18047525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP31395790A Pending JPH04186163A (en) | 1990-11-21 | 1990-11-21 | Automatic analyzing device |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH04186163A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007298444A (en) * | 2006-05-01 | 2007-11-15 | Olympus Corp | Analyzer |
-
1990
- 1990-11-21 JP JP31395790A patent/JPH04186163A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007298444A (en) * | 2006-05-01 | 2007-11-15 | Olympus Corp | Analyzer |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4252536A (en) | Method and system for measuring blood coagulation time | |
| US7828729B2 (en) | Method of measuring bleeding volume | |
| CN113039436B (en) | Analytical methods, analytical devices and analytical procedures | |
| US4338811A (en) | Method and apparatus for diagnosis of disease | |
| IL119904A0 (en) | An automated method for discriminating platelets from cells and apparatus for carrying out same | |
| JPH0746111B2 (en) | Sample analysis method and automatic analyzer using the same | |
| JP2016504580A (en) | Calibration process and system | |
| CN116057383A (en) | Analytical method of blood coagulation reaction | |
| CN105954527B (en) | Clinical sample automatic analytical instrument | |
| GB1570652A (en) | Automatic blood analyzing system | |
| JP2006010453A (en) | Interface detector, volume measuring instrument, and interface detecting method | |
| US20040218728A1 (en) | Calibration of the transformation of spectral X-ray attenuation values in density and atomic number information | |
| JPH04186163A (en) | Automatic analyzing device | |
| JPS60213850A (en) | Particle analyzer | |
| US4314346A (en) | Auxiliary apparatus for a particle analyser | |
| US20040219680A1 (en) | Method and apparatus for determining anticoagulant therapy factors | |
| JP2636051B2 (en) | Particle measurement method and device | |
| JPH05151282A (en) | Clinical inspection system | |
| EP0010526B1 (en) | Method and apparatus for investigating haemocoagulation or aggregation of platelets | |
| WO2023216637A1 (en) | Sample analyzer and state prompting method therefor, and computer device and storage medium | |
| JP3390873B2 (en) | Method for detecting M protein in serum protein fraction | |
| JP4627602B2 (en) | Radioactivity measuring device and radioactivity measuring method | |
| JP2011075493A (en) | Blood analyzer | |
| JP4920450B2 (en) | Automatic analyzer and accuracy control method thereof | |
| JP2017049098A (en) | X-ray fluorescence analyzer, X-ray fluorescence analysis method, and computer program |